Joel in the video says the reason is to "maximize value"
"Without a doubt... believe we are undervalued...compared to companies on the NASDAQ"
In all fairness....Gotta check some facts here re: Nasdaq comparables and recent performances
ATAI - Approaching YTD Highs - Market Cap 371 M $US
Compass - At YTD Highs - MKT CAP 422M $US
Mindmed At YTD Highs - Mkt Cap US$155M
Incannex IXHL - Market Cap $127 M US
If were to be comparable to other stocks in the psychedelics sector where would our price be currently???
Clearly, we are still down considerably compared to the other YTD
Good luck all